BridgeMD
New treatment option for Parkinson Disease
Official title Patient-Specific 3D Action Observation Training in Parkinson's Disease
ClinicalTrials.gov ID: NCT07250672
What this study is testing
- What it's testing
- Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 85
You may be able to join if
- Voluntary agreement to participate in the study
- Clinical diagnosis of Parkinson's disease confirmed by a neurologist
- Ongoing treatment with antiparkinsonian medication
- Hoehn and Yahr (H-Y) stage ≤ 3
- Ability to walk independently
You likely can't join if
- Presence of additional neurological disorders other than Parkinson's disease
- Change in medication dosage within the past month
- Score of ≥ 10 on the Simulator Sickness Questionnaire
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)
The study team makes the final eligibility decision.
Where it's taking place
- Bolu, Bolu, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bolu, Bolu, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.